- Treatment of hepatitis B and C
- Clinical trials in viral hepatitis
- Management of antiviral-resistant hepatitis B
Safety, Efficacy and Pharmacodynamics of Vesatolimod (GS-9620) in Virally-Suppressed Patients with Chronic Hepatitis B.
J Hepatol. 2017 Nov 02;:
The experience of patients with cancer during diagnosis and treatment planning: a descriptive study of Canadian survey results.
Curr Oncol. 2017 Oct;24(5):332-337
In Vivo Confocal Microscopy Reveals Corneal Reinnervation After Treatment of Neurotrophic Keratopathy With Corneal Neurotization.
Cornea. 2017 Oct 17;:
Abdom Radiol (NY). 2017 Sep 26;:
Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
Ophthalmology. 2017 Aug 11;:
Curr Oncol. 2017 Jun;24(3):201-206
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):185-195
Pediatr Surg Int. 2016 Nov 28;
Curr Oncol. 2016 Oct;23(5):351-355
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.
Aliment Pharmacol Ther. 2016 Sep 15;
Clinical Researcher, Toronto General Hospital Research Institute (TGHRI)
Assistant Professor, Department of Medicine, University of Toronto
Site Director, Gastroenterology Education, Toronto General Hospital
GI Education Coordinator for General Internal Medicine, UHN and Mount Sinai Hospital